zintick

Vaxcyte PCVX

Vaxcyte, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$62.61+1.87%close on Oct. 29, 2026 · volume 2.0M · Yahoo Finance

Price, last 48 sessions

$60.00$65.00$70.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 29, 2026 · high $73.82 · low $56.05 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 5, 2026Jim Wassil
EVP, Chief Scientific Ofc, COO
Sold
10b5-1 plan
18,000$86.74$1.56 million
Oct. 5, 2026Elvia Cowan
SVP, Finance & CAO
Sold
10b5-1 plan
19,000$86.74$1.65 million
Oct. 1, 2026Jim Wassil
EVP, Chief Scientific Ofc, COO
Sold
10b5-1 plan
2,250$56.67
$56.65-$57.09
$127,513
Sept. 9, 2026Jim Wassil
EVP, Chief Scientific Ofc, COO
Sold1,334$59.52$79,401
Sept. 4, 2026Jim Wassil
EVP, Chief Scientific Ofc, COO
Sold1,381$61.16$84,462
Sept. 1, 2026Jim Wassil
CHIEF OPERATING OFFICER
Sold3,477$61.07
$60.89-$61.48
$212,352
Aug. 5, 2026Harpreet S. Dhaliwal
Chief Technical Ops Officer
Sold
10b5-1 plan
17,000$55.00$935,068
Aug. 3, 2026Jim Wassil
CHIEF OPERATING OFFICER
Sold
10b5-1 plan
2,250$53.86
$53.50-$54.09
$121,195
Aug. 3, 2026Andrew Guggenhime
PRESIDENT AND CFO
Sold
10b5-1 plan
10,000$53.89
$53.76-$54.18
$538,879
July 27, 2026Grant Pickering
CHIEF EXECUTIVE OFFICER, director
Sold
10b5-1 plan
16,198$55.63
$55.52-$55.93
$901,069
July 27, 2026Grant Pickering
CHIEF EXECUTIVE OFFICER, director · indirect
Sold
10b5-1 plan
2,000$55.65
$55.52-$55.96
$111,307

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 30 →